Back to Search Start Over

Supplementary Methods, Table 1 from A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Authors :
Razelle Kurzrock
Jessica Vermeulen
Brenda Tromp
Helgi van de Velde
Rajesh Bandekar
Thomas A. Puchalski
Brett Hall
Manjula Reddy
Neil Steven
Jean-Pascal Machiels
Luc Dirix
Isabelle Ray-Coquard
Florence Joly
Sally Clive
Jose A. Lopez-Martin
Christian Ottensmeier
Jean-Luc van Laethem
Rastilav Bahleda
Steven J. Cohen
Elena Elez
Josep Tabernero
Eric Angevin
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

PDF file - 99KB, Supplementary Methods: The supplemental material contains additional detail on the pharmacokinetic and pharmacodynamic methods used during the study as well as a summary table of safety events and a figure detailing patient disposition. Supplemental Table 1: Summary of safety events in all study cohorts.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....1341526889b62e8ae6ca5a284139b85a